Association of Northern California Oncologists

http://www.anco.org/

 

ANCO’s ASCO Highlights 2019
K

ANCO's ASCO Update: NIVO + IPI - New First-Line Therapy for Asymptomatic Melanoma Brain Metastases?

By ANCO’s ASCO Highlights 2019 FEATURING Katy K. Tsai
By ANCO’s ASCO Highlights 2019 FEATURING Katy K. Tsai
0 views
September 12, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Skin
10:10
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update: NIVO + IPI - New First-Line Therapy for Asy…

Feat. K. Tsai
08:19
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update: Adjuvant Whole-Brain Radiotherapy Not Recom…

Feat. K. Tsai
10:31
ANCO’s ASCO Highlights 2019

ANCO's ASCO 2019: Is Neoadjuvant Therapy Suited for Melanoma?

Feat. K. Tsai